|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Operating expenses | |
| Research and development expenses | |
| General and administrative expenses | |
| Intangible asset and Goodwill Impairment expenses | |
| Operating loss | |
| Financial expense (income), net | |
| Loss before tax expenses | |
| Tax expenses | |
| Successor | |
| Total tax expenses | |
| Net loss and comprehensive loss | |
| Successor | |
| Total net loss and comprehensive loss | |
| Basic net loss per share to shareholders of the parent Company (in Dollars per share) | |
| Successor | |
| Total basic net loss per share to shareholders of the parent Company (in Dollars per share) | |
| Diluted net loss per share to shareholders of the parent Company (in Dollars per share) | |
| Successor | |
| Total diluted net loss per share to shareholders of the parent Company (in Dollars per share) | |
| Weighted average number of ordinary shares used in computing basic net loss per share (in Shares) | |
| Successor | |
| Total weighted average number of ordinary shares used in computing basic net loss per share (in Shares) | |
| Weighted average number of ordinary shares used in computing diluted net loss per share (in Shares) | |
| Successor | |
| Total weighted average number of ordinary shares used in computing diluted net loss per share (in Shares) |
Loading...
